Back to mobile site

UBS Maintains a 'Buy' on Watson Pharmaceuticals (WPI); Love Me Two Times

March 11, 2011 11:42 AM EST Send to a Friend
UBS maintains a 'Buy' on Watson Pharmaceuticals (NYSE: WPI), PT increased from $64 to $69.

UBS analyst says, "What’s new? ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login